About Enovis
Enovis is a company based in United States founded in 2022. The company has 7,370 employees as of December 31, 2024. Enovis has completed 2 acquisitions, including Lima Corporate and Novastep. Enovis offers products and services including Bracing and Supports and Surgical Implants.
- Headquarter United States
- Employees 7370 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Enovis Corporation
-
Annual Revenue
$2.11 B (USD)23.46as on Dec 31, 2024
-
Net Profit
-$825.49 M (USD)-1592.35as on Dec 31, 2024
-
EBITDA
$281.17 M (USD)32.42as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
7370
as on Dec 31, 2024
-
Investments & Acquisitions
Lima Corporate
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Enovis
Enovis is a publicly listed company on the NYSE with ticker symbol ENOV in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Enovis
Enovis offers a comprehensive portfolio of products and services, including Bracing and Supports and Surgical Implants.
Bracing and supports for body parts like knees and ankles are offered to aid in protection and recovery processes.
Surgical implants for joints such as hips and shoulders are provided to restore movement and improve quality of life.
People of Enovis
Unlock access to complete
Software Development Team
106 people
Sales and Marketing
67 people
Leadership Team
58 people
Finance and Accounting
28 people
Human Resources and Administration
21 people
Product Management Team
20 people
Senior Team
16 people
Operations Team
13 people
Unlock access to complete
Funding Insights of Enovis
Investments & Acquisitions by Enovis
Enovis has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Lima Corporate and Novastep.
Investment portfolio details for Enovis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Medical devices for foot and ankle injuries are developed.
|
Locked | Locked | 2019 | Locked | |
|
Large joint primary and revision 3D printed implants for hip and knee, and fixation devices
|
Locked | Locked | 1945 | Locked |
Complete acquisition details for Enovis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Enovis
Detailed financials for Enovis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Enovis Comparisons
Peer comparison for Enovis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Enovis
Detailed competitors of Enovis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Enovis
Complete news archive for Enovis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Enovis
Enovis was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Enovis is headquartered in United States.
Matthew L Trerotola is the current CEO of Enovis.
As of Dec 31, 2024, the latest employee count at Enovis is 7,370.
Annual revenue of Enovis is $2.11B as on Dec 31, 2024.
Enovis was founded in 2022 and is headquartered in the United States. Medical devices and equipment are produced by the company for bracing and support of various body parts, surgical implants, and recovery tools. Solutions are offered for foot and ankle care, diabetic footwear, bone healing regeneration, and spinal fusion. Muscle stimulators, therapy systems, and associated healthcare products are also provided within the medical devices sector.
Enovis offers Bracing and Supports and Surgical Implants.
Yes, Enovis is publicly traded on NYSE under the ticker symbol ENOV.
Enovis has made 2 acquisitions, including Lima Corporate, and Novastep.
The ticker symbol of Enovis is ENOV on NYSE.